Virtual Management of Rheumatoid Arthritis

Evaluation of Rheumatoid Arthritis at the Time of Telemedicine

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05124782

Acronym

ePRAT

Enrollment

Registered

2021-11-18

Start date

2021-11-30

Completion date

2023-11-22

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid arthritis, Virtual consultation, Telemedicine, Patient reported outcome

Brief summary

The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.

Detailed description

This study will be organized in two consecutive steps: 1. A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period. 2. The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.

Interventions

OTHERRheumatoid Arthritis Impact of Disease questionnaire

Rheumatoid Arthritis Impact of Disease questionnaire

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria * Follow-up in the rheumatology department of Cochin Hospital * Affiliated with a social security scheme * Non-opposition to participating in the study * Patients with a valid email address (registration to the virtual consultation system)

Exclusion criteria

* Opposition to participate to this research * Inability to understand or speak French * Patient under tutor or curator ship * patients under medical state help

Design outcomes

Primary

Measure	Time frame	Description
Rate of face to face consultation, hospitalization and therapeutic modifications	Inclusion	The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026